31 related articles for article (PubMed ID: 38445546)
1. Combination of proton- or X-irradiation with anti-PDL1 immunotherapy in two murine oral cancers.
Rykkelid AM; Sinha PM; Folefac CA; Horsman MR; Sørensen BS; Søland TM; Schreurs OJF; Malinen E; Edin NFJ
Sci Rep; 2024 May; 14(1):11569. PubMed ID: 38773258
[TBL] [Abstract][Full Text] [Related]
2. Dynamic Proteomic Changes in Tumor and Immune Organs Reveal Systemic Immune Response to Tumor Development.
Li Z; Liu S; Gao Z; Ji L; Jiao J; Zheng N; Li X; Wang G; Qin J; Wang Y
Mol Cell Proteomics; 2024 May; 23(5):100756. PubMed ID: 38554776
[TBL] [Abstract][Full Text] [Related]
3. Model for mediastinal lymph node metastasis produced by orthotopic intrapulmonary implantation of lung cancer cells in mice.
Yamaura T; Doki Y; Murakami K; Saiki I
Hum Cell; 1999 Dec; 12(4):197-204. PubMed ID: 10834106
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the tumor microenvironment in the mouse oral cancer (MOC1) model after orthotopic implantation in the buccal mucosa.
Kansal V; Kinney BLC; Schmitt NC
Head Neck; 2024 May; 46(5):1056-1062. PubMed ID: 38445546
[TBL] [Abstract][Full Text] [Related]
5. Orthotopic injection of an established syngeneic mouse oral cancer cell line (MOC1) induces a robust draining lymph node response.
Kansal V; Kinney BLC; Schmitt NC
bioRxiv; 2024 Jan; ():. PubMed ID: 38260311
[TBL] [Abstract][Full Text] [Related]
6. Enhanced oral versus flank lymph node T cell response parallels anti-PD1 efficacy in head and neck cancer.
Kono M; Saito S; Rokugo M; Egloff AM; Uppaluri R
Oral Oncol; 2024 May; 152():106795. PubMed ID: 38599127
[TBL] [Abstract][Full Text] [Related]
7. HPV-positive murine oral squamous cell carcinoma: development and characterization of a new mouse tumor model for immunological studies.
Modic Z; Cemazar M; Markelc B; Cör A; Sersa G; Kranjc Brezar S; Jesenko T
J Transl Med; 2023 Jun; 21(1):376. PubMed ID: 37296466
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of tumor-infiltrating lymphocytes in a syngeneic mouse model of oral cancer.
Judd NP; Allen CT; Winkler AE; Uppaluri R
Otolaryngol Head Neck Surg; 2012 Sep; 147(3):493-500. PubMed ID: 22434099
[TBL] [Abstract][Full Text] [Related]
9. Malignant cell-specific CXCL14 promotes tumor lymphocyte infiltration in oral cavity squamous cell carcinoma.
Parikh A; Shin J; Faquin W; Lin DT; Tirosh I; Sunwoo JB; Puram SV
J Immunother Cancer; 2020 Sep; 8(2):. PubMed ID: 32958684
[TBL] [Abstract][Full Text] [Related]
10. Heterozygous OT-I mice reveal that antigen-specific CD8
Zöphel D; Kaschek L; Steiner R; Janku S; Chang HF; Lis A
Aging Cell; 2023 Jun; 22(6):e13824. PubMed ID: 36947105
[TBL] [Abstract][Full Text] [Related]
11. Statin drugs enhance responses to immune checkpoint blockade in head and neck cancer models.
Kansal V; Burnham AJ; Kinney BLC; Saba NF; Paulos C; Lesinski GB; Buchwald ZS; Schmitt NC
J Immunother Cancer; 2023 Jan; 11(1):. PubMed ID: 36650022
[TBL] [Abstract][Full Text] [Related]
12. Elective nodal irradiation mitigates local and systemic immunity generated by combination radiation and immunotherapy in head and neck tumors.
Darragh LB; Gadwa J; Pham TT; Van Court B; Neupert B; Olimpo NA; Nguyen K; Nguyen D; Knitz MW; Hoen M; Corbo S; Joshi M; Zhuang Y; Amann M; Wang XJ; Dow S; Kedl RM; Samedi V; Boss MK; Karam SD
Nat Commun; 2022 Nov; 13(1):7015. PubMed ID: 36385142
[TBL] [Abstract][Full Text] [Related]
13. Lymphatic-preserving treatment sequencing with immune checkpoint inhibition unleashes cDC1-dependent antitumor immunity in HNSCC.
Saddawi-Konefka R; O'Farrell A; Faraji F; Clubb L; Allevato MM; Jensen SM; Yung BS; Wang Z; Wu VH; Anang NA; Msari RA; Schokrpur S; Pietryga IF; Molinolo AA; Mesirov JP; Simon AB; Fox BA; Bui JD; Sharabi A; Cohen EEW; Califano JA; Gutkind JS
Nat Commun; 2022 Jul; 13(1):4298. PubMed ID: 35879302
[TBL] [Abstract][Full Text] [Related]
14. The mouse oral carcinoma (MOC) model: A 10-year retrospective on model development and head and neck cancer investigations.
Kono M; Saito S; Egloff AM; Allen CT; Uppaluri R
Oral Oncol; 2022 Sep; 132():106012. PubMed ID: 35820346
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
